DOJ Shift On Pay-For-Delay Puts Focus On Courts

Law360, New York (April 14, 2009, 12:00 AM EDT) -- In a reversal of its stance under the Bush administration, the U.S. Department of Justice this week aligned itself with the Federal Trade Commission against “pay-for-delay” settlements between branded-drug makers and their generics competitors, a move experts say could inspire courts to rethink their views of the deals.

On Monday, the DOJ filed a brief with the U.S. Court of Appeals for the Second Circuit, saying pay-for-delay settlements in patent lawsuits were presumptively unlawful and that drug companies should offer justifications in order to avoid antitrust...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.